Head-to-head · Cost-Efficiency Index
MEDGm vs Allara Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
MEDGm
Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.
Visit MEDGmAllara Health
Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself.
Visit Allara HealthThe verdict
Allara Health takes it, leading the Cost-Efficiency Index 62 to 60. Allara Health is an insurance-accepting telehealth platform for women's hormonal and metabolic health (including PCOS), prescribing FDA-approved brand GLP-1s (Wegovy, Zepbound) among other treatments. MEDGm still earns a C — Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Allara Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | MEDGm | Allara Health |
|---|---|---|
| Cost-Efficiency Index | 60/100 | 62/100 |
| Semaglutide / mo | $299/mo month-to-month (the advertised $179 is the first month only, after an automatically applied coupon) | $149/mo (plus a separate fee, brand-name) |
| Tirzepatide / mo | $399/mo month-to-month (the advertised $279 is the first month only) | Not disclosed |
| Semaglutide / yr (modeled) | $3,588 | $1,788 |
| Tirzepatide / yr (modeled) | $4,788 | — |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #203 | #204 |
MEDGm
60/100Where the value is
- Names all four pharmacy partners in its terms, with street addresses, phone numbers and websites, and says which compounding classes they operate under
- Names seven prescribing professional corporations on its consent page rather than referring to an unnamed medical group
- Publishes the full ladder for three GLP-1 routes — injection, oral tablet and tirzepatide — at one, three, six and twelve months
The tradeoffs
- "Starting at $179" is a first-month rate produced by an automatically applied coupon; the standing month-to-month price is $299, and the same shape applies to the oral tablet and to tirzepatide
- The treatments FAQ says "your price never increases" on a plan whose price increases by $120 at the first renewal
Allara Health
62/100Where the value is
- In-network with major insurers (Aetna, Blue Cross Blue Shield/Anthem/Carefirst, Cigna, United Healthcare/Oxford/UMR, GEHA), which can make branded GLP-1s cheaper than any cash-pay compounded option for covered patients
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) rather than unapproved compounded preparations
- Board-certified OB-GYNs, endocrinologists, and Registered Dietitians on a women's-health-specialized platform
The tradeoffs
- No GLP-1 medication price is published anywhere on the site — the $149/mo figure is a visit/membership fee only, and actual drug cost depends entirely on insurance or is undisclosed for self-pay
- Not a general low-cost GLP-1 shopping option — the platform is built around women's hormonal/PCOS specialty care, with GLP-1 as one treatment among many
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.